Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
This study is not yet open for participant recruitment.
Verified by HaEmek Medical Center, Israel, July 2007
Sponsored by: HaEmek Medical Center, Israel
Information provided by: HaEmek Medical Center, Israel
ClinicalTrials.gov Identifier: NCT00512564
  Purpose

Iron overload is well study in Thalassemia patients and it's not only related to blood transfusions, since intestinal iron absorption is also increased in those patients. Sickle cell patients didn't developed significant clinical symptoms and signs of iron overload in spite frequent transfusions. The purpose of this study is to assess the iron overload in Sickle cell anemia and Sickle cell Thalassemia patients using clinical parameters and laboratory studies including Non Transferrin Binding Iron, Labile Iron and Hepcidin, in order to determine the cardiac and liver iron.


Condition
Sickle Cell Anemia
Sickle Cell Thalassemia

Genetics Home Reference related topics: beta thalassemia sickle cell disease
MedlinePlus related topics: Anemia Sickle Cell Anemia Thalassemia
U.S. FDA Resources
Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Retrospective/Prospective Study

Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment: 50
Study Start Date: September 2007
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All the patients with Sickle Cell Anemia and Sickle Cell Thalassemia that are treated and followed up at the Pediatric Hematology Unit.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00512564

Contacts
Contact: Ariel Koren, MD 972-4-6495576 ext 5576 koren_a@clalit.org.il
Contact: Carina Levin, MD 972-4-6494189 ext 4189 levin_c@clalit.org.il

Locations
Israel
Pediatric Hematology Unit - HaEmek Medical Center
Afula, Israel, 18101
Pediatric Hematology Unit - HaEmek Medical Center
Afula, Israel, 1810
Sponsors and Collaborators
HaEmek Medical Center, Israel
Investigators
Principal Investigator: Ariel Koren, MD Pediatric Hematology Unit, Ha'Emek Medical Center
  More Information

Study ID Numbers: 0087-07-EMC
Study First Received: August 5, 2007
Last Updated: August 6, 2007
ClinicalTrials.gov Identifier: NCT00512564  
Health Authority: Israel: Ministry of Health

Keywords provided by HaEmek Medical Center, Israel:
Sickle Cell Anemia
Sickle Cell Thalassemia
Iron overload
Non transferrin binding iron
Hepcidin

Study placed in the following topic categories:
Metabolic Diseases
Hematologic Diseases
Anemia
Anemia, Hemolytic
Iron Metabolism Disorders
Thalassemia
Sickle cell anemia
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hemoglobinopathies
Iron Overload
Metabolic disorder
Hemoglobinopathy
Iron
Anemia, Sickle Cell

ClinicalTrials.gov processed this record on January 15, 2009